Familial dysalbuminemic hyperthyroxinemia may result in altered warfarin pharmacokinetics
- 1 February 2000
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 124 (3), 161-172
- https://doi.org/10.1016/s0009-2797(99)00143-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Novel Missense Mutation in Codon 218 of the Albumin Gene in a Distinct Phenotype of Familial Dysalbuminemic Hyperthyroxinemia in a Japanese KindredJournal of Clinical Endocrinology & Metabolism, 1997
- Mutagenesis Studies of Thyroxine Binding to Human Serum Albumin Define an Important Structural Characteristic of Subdomain 2ABiochemistry, 1997
- An Identical Missense Mutation in the Albumin Gene Results in Familial Dysalbuminemic Hyperthyroxinemia in Eight Unrelated FamiliesBiochemical and Biophysical Research Communications, 1994
- A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia.Journal of Medical Genetics, 1994
- Atomic structure and chemistry of human serum albuminNature, 1992
- Euthyroid familial hyperthyroxinemia due to abnormal thyroid hormone-binding proteinAmerican Journal Of Medicine, 1982
- INHERITED THYROXINE EXCESS: A SERUM ABNORMALITY DUE TO AN INCREASED AFFINITY FOR MODIFIED ALBUMINClinical Endocrinology, 1981
- Familial Euthyroid Thyroxine Excess: An Appropriate Response to Abnormal Thyroxine Binding Associated with AlbuminJournal of Clinical Endocrinology & Metabolism, 1981
- Inherited Abnormal Thyroid Hormone-Binding Protein Causing Selective Increase of Total Serum Thyroxine*Journal of Clinical Endocrinology & Metabolism, 1979
- Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin‐alcoholClinical and Experimental Pharmacology and Physiology, 1975